Company Phoenix Life Sciences International Limited Other OTC
Equities
PLSI
US71910Q1022
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Lewis Humer
CHM | Chairman | 65 | 14-04-24 |
Stephen Cornford
CIO | Chief Investment Officer | - | - |
David Steinman
LAW | General Counsel | - | 19-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Humer
CHM | Chairman | 65 | 14-04-24 |
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,084,582 | 8,644,192 ( 85.72 %) | 0 | 85.72 % |
Company contact information
Phoenix Life Sciences International Ltd.
1810 East Sahara Avenue Suite 215
89139, Las Vegas
+
http://www.phoenixlife.co![address Phoenix Life Sciences International Limited(PLSI)](https://cdn.zonebourse.com/static/address/24695429.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+56.45% | 815B | |
+43.90% | 641B | |
-6.82% | 352B | |
+17.35% | 314B | |
+9.65% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+8.08% | 168B |